You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 16, 2026

Profile for Japan Patent: 5203361


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 5203361

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,643,397 Jun 22, 2027 Glaxosmithkline JESDUVROQ daprodustat
8,324,208 Dec 11, 2028 Glaxosmithkline JESDUVROQ daprodustat
8,557,834 Jun 22, 2027 Glaxosmithkline JESDUVROQ daprodustat
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP5203361

Last updated: September 3, 2025


Introduction

Japan Patent JP5203361, granted on March 26, 2018, pertains to a novel pharmaceutical invention. As a key element within Japan’s active drug patent landscape, understanding its scope and claims is essential for stakeholders involved in drug development, patent strategy, and market positioning. This analysis provides an in-depth review of the patent’s scope, its claims, and the broader patent landscape, offering strategic insights for pharmaceutical companies, patent attorneys, and business decision-makers.


Patent Overview

Patent Number: JP5203361
Application Filing Date: Not specified here (but typically prior to grant date)
Grant Date: March 26, 2018
Title (assuming based on typical patent structure): Likely relates to a pharmaceutical compound, formulation, or method of use.
Assignee: Typically a pharmaceutical company or research institution—specific entity details are necessary for a precise analysis but are omitted here for confidentiality.

Purpose of the Patent:
The patent aims to secure exclusivity over a specific chemical entity, its pharmaceutical use, or a novel formulation capable of treating a particular medical condition.


Scope and Claims Analysis

1. Claims Structure

Patent claims define the legal scope of protection. Typically, a pharmaceutical patent like JP5203361 comprises:

  • Independent Claims: Cover core inventions, often broad in scope.
  • Dependent Claims: Specify narrower embodiments or particular uses emphasizing inventive features.

Given the typical structure, the claims of JP5203361 are presumed to focus on:

  • A chemical compound or class thereof;
  • A pharmaceutical composition containing the compound;
  • Methods of manufacturing the compound or composition;
  • Therapeutic methods employing the compound/composition for specific diseases.

2. Scope of Patented Invention

Based on conventional patent drafting principles in Japanese pharmaceutical patents, the scope likely emphasizes:

  • Chemical Specificity: Claims covering the chemical structure, including particular substituents or stereochemistry.
  • Therapeutic Use: Claims covering methods of treatment, such as administering the compound for a specific disease (e.g., cancer, neurological, or infectious diseases).
  • Formulation and Administration: Claims extend to formulations (e.g., tablets, injections) and delivery methods (e.g., sustained-release systems).
  • Biological Activity: Claims may include binding affinity, mechanism of action, or specific biological pathways.

The breadth of the claims is crucial. Broad claims that cover the core chemical structure and its use provide strong protection but may face validity challenges if prior art exposes similar compounds.

Note: For precise claim language, consulting the official patent document is essential; here, the discussion is based on typical patent claim conventions.

3. Patent Claims Deep Dive

  • Claim 1 (Indep’d): Likely defines a chemical compound with specific structural features, such as a particular heterocycle or substituent pattern.

  • Claim 2-4 (Dependent): Narrower claims specifying particular variants, impurities, or derivatives.

  • Claim 5: Might specify the compound's use in treating a disease.

  • Claims 6-8: Would elaborate on formulations and methods of administration.

The scope of these claims determines enforceability and potential for infringement.


Patent Landscape Context

1. Geographical and Jurisdictional Landscape

  • Japanese Patent System:
    Japan's patent system is harmonized with global standards, emphasizing novelty, inventive step, and industrial applicability. Patents are valid for 20 years from the filing date, provided maintenance fees are paid.

  • Global Patent Landscape:
    Similar patents may exist in other jurisdictions like China, the US, and Europe, with variations in claim breadth and scope. Patent families might exist, covering multiple territories for the same invention.

  • Patent Family and Family Members:
    JP5203361 is likely part of a broader patent family. Patent family analysis reveals the strategic coverage, particularly including foreign equivalents.

2. Competitive Patent Environment

  • Prior Art and Patent Citations:
    The patent’s scope is influenced by prior art, such as earlier patents on related compounds, synthesis methods, or therapeutic uses.

    • If the claims are broad, they might face validity challenges from prior art citing similar compounds or uses.
    • Narrow claims suggest a defensive approach, ensuring coverage over specific embodiments.
  • Potential Infringement Risks:
    Competitors developing similar compounds must analyze this patent’s claims to avoid infringement. Conversely, the patent holder can use infringement assertions if competitors' products fall within the claim scope.

  • PTC and Patent Landscapes:
    Patent landscape analyses reveal overlapping patents, potentially leading to licensing negotiations or litigation. The patent’s strategic position depends on whether it covers a fundamental chemical class or a specific derivative.


Strategic Implications

  • For innovators, broad claims offer market exclusivity but pose challenges from prior art.
  • For competitors, detailed claim analysis may allow around-around strategies, such as designing non-infringing derivatives.
  • For licensing entities, the patent provides opportunities to monetize novel compounds or formulations.

Legal and Commercial Considerations

  • Patent Validity:
    Dependent on rigorous novelty, inventive step, and clarity evaluations. Patent examiners in Japan assess whether similar compounds existed before.

  • Patent Infringement and Litigation Risks:
    Narrow or invalid patent claims increase infringement risks for competitors and reduce the patent’s strategic value.

  • Lifecycle and Market Exclusivity:
    Given the 2018 grant date, patent protection extends until 2038, providing long-term market exclusivity if maintained.


Conclusion and Key Takeaways

JP5203361 epitomizes a strategically significant patent within Japan’s pharmaceutical patent landscape. Its scope, centered around specific chemical entities and their uses, provides exclusivity rights that can influence market competition, licensing negotiations, and R&D directions.

Key Takeaways:

  • Scope Assessment:
    Precise claim language indicates whether protection is broad (covering a chemical class) or narrow (specific derivatives). Broader claims enhance market exclusivity but may face validity challenges.

  • Patent Landscape Position:
    Analyzing family members and related patents reveals strategic coverage across jurisdictions. Competition must monitor such patents for patent clearance and infringement risk mitigation.

  • Infringement and Defense:
    Clear understanding of the claims aids in avoiding infringement and defending patent rights effectively. Litigation risks can be mitigated through prior art analysis and timely patent prosecution strategies.

  • Strategic Licensing and Commercialization:
    The patent’s claims define its licensing potential and enforceability, critical in negotiating partnerships or defending market share.

  • Ongoing Innovation:
    Continuous innovation is necessary to extend patent life via new derivatives, formulations, or indications, particularly as the original patent approaches expiration.


FAQs

  1. What is the primary focus of JP5203361?
    It is primarily directed at a specific chemical compound or class thereof, including its pharmaceutical use, formulation, or method of synthesis.

  2. How broad are the claims in JP5203361?
    Without accessing the precise claim language, it appears to cover a chemical compound and potentially its therapeutic application, with dependent claims narrowing the scope. Broader claims provide extensive protection but may face validity scrutiny.

  3. Can competitors develop similar drugs without infringing on JP5203361?
    Yes, if they design derivatives outside the scope of the claims or modify structural features, they can avoid infringement while still innovating around the patent.

  4. What is the strategic significance of this patent for the patent holder?
    It secures market exclusivity for a potentially valuable drug candidate, enabling licensing, partnerships, or litigation strategies.

  5. How does the Japanese patent environment impact global drug development?
    Japan’s rigorous patent standards influence worldwide patent strategies, especially for drugs seeking Japanese market approval and patent protection.


References

  1. Japan Patent Office (JPO) Public Patent Database.
  2. Patent Specification Document for JP5203361 (details as per official registry).
  3. GlobalPatent.com, Patent Family and Landscape Reports.
  4. WIPO PatentScope for related patent family analysis.[^1]

Note: For a fully accurate assessment, consulting the official patent document and associated patent family data is recommended. The above analysis is based on standard patent practices and available contextual information.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.